RG
SLN

Redmile Group’s Silence Therapeutics SLN Stock Holding History

Redmile Group’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Hold
2,164,777
– – 0.76% 21
2025
Q4 		$13.2M Hold
2,164,777
– – 0.97% 17
2025
Q3 		$11.2M Hold
2,164,777
– – 1.09% 22
2025
Q2 		$12.6M Sell
2,164,777
-50,170
-2% -$215K 1.34% 20
2025
Q1 		$6.25M Sell
2,214,947
-184,370
-8% -$900K 0.59% 32
2024
Q4 		$16.5M Buy
2,399,317
+500,000
+26% +$6.45M 1.15% 25
2024
Q3 		$34.5M Sell
1,899,317
-114,979
-6% -$2.14M 2.03% 24
2024
Q2 		$38.3M Sell
2,014,296
-13,373
-0.7% -$284K 2.31% 16
2024
Q1 		$43.8M Buy
+2,027,669
New +$44.1M 1.61% 23

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $509M AUM 24.47% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return